CN Patent

CN112979654B — 杂芳基稠环化合物、其制备方法及应用

Assigned to Scinnohub Pharmaceutical Co Ltd · Expires 2024-03-19 · 2y expired

What this patent protects

本发明提供了一种新的取代的杂芳基稠环化合物、其制备方法，其可用作TRK抑制剂，在黑色素瘤、肺癌、头颈癌、胰腺癌、乳腺癌、甲状腺癌、神经胶质瘤等TRK激酶介导的疾病中具有广泛良好的应用前景。

USPTO Abstract

本发明提供了一种新的取代的杂芳基稠环化合物、其制备方法，其可用作TRK抑制剂，在黑色素瘤、肺癌、头颈癌、胰腺癌、乳腺癌、甲状腺癌、神经胶质瘤等TRK激酶介导的疾病中具有广泛良好的应用前景。

Drugs covered by this patent

Patent Metadata

Patent number
CN112979654B
Jurisdiction
CN
Classification
—
Expires
2024-03-19
Drug substance claim
No
Drug product claim
No
Assignee
Scinnohub Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.